Apathy

"Apathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Lack of emotion or emotional expression; a disorder of motivation that persists over time.

Descriptor ID	D057565
MeSH Number(s)	F01.470.137
Concept/Terms	Apathy Apathy

Below are MeSH descriptors whose meaning is more general than "Apathy".

Psychiatry and Psychology [F]
Behavior and Behavior Mechanisms [F01]
Emotions [F01.470]
Apathy [F01.470.137]

Below are MeSH descriptors whose meaning is related to "Apathy".

Below are MeSH descriptors whose meaning is more specific than "Apathy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Apathy" by people in this website by year, and whether "Apathy" was a major or minor topic of these publications.

Bar chart showing 14 publications over 8 distinct years, with a maximum of 3 publications in 2013 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	1	0	1
2013	3	0	3
2015	0	1	1
2016	0	1	1
2018	3	0	3
2019	0	1	1
2020	2	0	2
2021	2	0	2

Below are the most recent publications written about "Apathy" by people in Profiles.

Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332.

View in: PubMed
Miller DS, Robert P, Ereshefsky L, Adler L, Bateman D, Cummings J, DeKosky ST, Fischer CE, Husain M, Ismail Z, Jaeger J, Lerner AJ, Li A, Lyketsos CG, Manera V, Mintzer J, Moebius HJ, Mortby M, Meulien D, Pollentier S, Porsteinsson A, Rasmussen J, Rosenberg PB, Ruthirakuhan MT, Sano M, Zucchero Sarracini C, Lanctôt KL. Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. 2021 12; 17(12):1892-1904.

View in: PubMed
Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89.

View in: PubMed
van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry. 2021 01; 29(1):51-62.

View in: PubMed
Grubaugh AL, Myers US, Keller SM, Wangelin BC, Lozano BE, Tuerk PW. An adjunctive human-animal interaction intervention for veterans with PTSD: study protocol for a randomized controlled trial. Trials. 2019 Dec 27; 20(1):786.

View in: PubMed
Tareen TK, Artusi CA, Rodriguez-Porcel F, Devoto JL, Sheikh H, Mandybur GT, Duker AP, Espay AJ, Merola A. Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation. J Neurol Sci. 2018 07 15; 390:33-35.

View in: PubMed
Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46.

View in: PubMed
Mohammad D, Ellis C, Rau A, Rosenberg PB, Mintzer J, Ruthirakuhan M, Herrmann N, Lanctôt KL. Psychometric Properties of Apathy Scales in Dementia: A Systematic Review. J Alzheimers Dis. 2018; 66(3):1065-1082.

View in: PubMed
Rosenberg PB, Lanctôt KL, Herrmann N, Mintzer JE, Porsteinsson AP, Sun X, Raman R. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease. J Alzheimers Dis. 2016 08 10; 54(1):373-81.

View in: PubMed
Williams NR, Hopkins TR, Short EB, Sahlem GL, Snipes J, Revuelta GJ, George MS, Takacs I. Reward circuit DBS improves Parkinson's gait along with severe depression and OCD. Neurocase. 2016; 22(2):201-4.

View in: PubMed

People

Explore

Similar Concepts

Top Journals